Skip to main content
Log in

Maintenance suppressive azole antifungal regimens are a major advance in controlling recurrent vulvovaginal candidiasis

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Table II
Table III

References

  1. Sobel JD. Vaginal infections in adult women. Med Clin North Am 1990; 74(6): 1573–602

    PubMed  CAS  Google Scholar 

  2. Sobel JD. Management of patients with recurrent vulvovaginal candidiasis. Drugs 2003; 63(11): 1059–66

    Article  PubMed  CAS  Google Scholar 

  3. Nwokolo NC, Boag FC. Chronic vaginal candidiasis. Management of the post menopausal patient. Drugs Aging 2000; 16(5): 335–9

    Article  PubMed  CAS  Google Scholar 

  4. Scharbo-DeHaan M, Anderson DG. The CDC 2002 guidelines for the treatment of sexually transmitted disease: implications for women’s health care. J Midwifery Womens Health 2003; 48(2): 96–104

    Article  PubMed  Google Scholar 

  5. Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 1985; 152: 924–35

    PubMed  CAS  Google Scholar 

  6. Sobel JD, Kapernik P, Zervos M, et al. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. Am J Obstet Gynecol 2001; 185: 363–9

    Article  PubMed  CAS  Google Scholar 

  7. Sobel JD, Faro S, Force RW et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998; 178: 203–11

    Article  PubMed  CAS  Google Scholar 

  8. Daniels D, Forster G. 2002 National guideline on the management of vulvovaginal candidiasis [online]. Available from: http://www.guideline.gov [Accessed 2004 Mar 10]

  9. Watson MC, Grimshaw JM, Bond CM et al. Oral versus intravaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database Syst Rev. 2001; (4): CD002845

  10. British National formulary. No. 47. London: The Pharmaceutical Press, 2004 Mar

  11. Diflucan product information [online]. Available from URL: http://www.diflucan.com [Accessed 2004 Mar 10]

  12. Sobel JD. Fluconazole maintenance therapy in recurrent vulvovaginal candidiasis. Int J Gynecol Obstet 1992; 37: 17–34

    Google Scholar 

  13. Spinillo A, Colonna L, Piazzi G, et al. Managing recurrent vulvovaginal candidiasis: intermittent prevention with itraconazole. J Reprod Med 1997; 42(2): 83–7

    PubMed  CAS  Google Scholar 

  14. Sobel JD. Recurrent vulvovaginal candidiasis: a prospective study of the efficacy of maintenance ketoconazole therapy. N Engl J Med 1986 Dec 4; 315(23): 1455–8

    Article  PubMed  CAS  Google Scholar 

  15. Fong IW. The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal candidiasis. Genitourin Med 1992; 68(6): 374–7

    PubMed  CAS  Google Scholar 

  16. Hilton E, Isenberg HD, Alperstein P, et al. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med 1992; 116(5): 353–7

    PubMed  CAS  Google Scholar 

  17. Lynch ME, Sobel JD. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates. J Med Vet Mycol 1994; 32: 267–74

    Article  PubMed  CAS  Google Scholar 

  18. Sobel JD, Chaim W. Therapy of T. glabrata vaginitis: retrospective review of boric acid therapy. Clin Infect Dis 1997; 24: 649–52

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maintenance suppressive azole antifungal regimens are a major advance in controlling recurrent vulvovaginal candidiasis. Drugs Ther. Perspect 20, 7–11 (2004). https://doi.org/10.2165/00042310-200420070-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200420070-00003

Navigation